Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)

Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: Analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)

Autor Sader, H. S. Google Scholar
Jones, R. N. Google Scholar
Gales, A. C. Google Scholar
Winokur, P. Google Scholar
Kugler, K. C. Google Scholar
Pfaller, M. A. Google Scholar
Doern, G. V. Google Scholar
SENTRY Latin Amer Study Grp Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Univ Iowa
Resumo Pneumonia is the mosi common fatal hospital-acquired infection, with attributable mortality rates ranging from 30 to 60%. Rapid initiation of optimal antimicrobial therapy is essential for obtaining treatment success. in this report the antimicrobial susceptibility of 556 strains from the lower respiratory tract were collected by the SENTRY Antimicrobial Surveillance Program (1997). These strains were isolated from hospitalized patients with pneumonia in 10 Latin American centers (6 countries) as part of this 68-center worldwide program. the isolates were susceptibility tested against more than 70 drugs (35 reported by) the reference broth microdilution method. Klebsiella pneumoniae and Escherichia coli phenotypically consistent with extended spectrum beta-lactamase (ESBL) production were characterized further by ribotyping and pulsed-field gel electrophoresis. the five most frequently isolated species mere (n/%): Pseudomonas aeruginosa (149/26.8%), Staphylococcus aureus (127/22.8%), Acinetobacter spp. (66/11.9%), Klebsiella spp. (56/10.1%), and Enterobacter spp. (40/7.2%). P. aeruginosa demonstrated high rates of resistance to a majority of the antimicrobial drugs tested. Carbapenems, amikacin, and piperacillin/tazobactam demonstrated the highest susceptibility rates (73.8-77.2%) against P. aeruginosa, however the lowest resistance rate was observed for cefepime (6.7%). Acinetobacter spp, also showed very high rates of resistance and the most active compounds were imipenem and meropenem (89.0% susceptibility) followed by the tetracyclines. Cephalosporin susceptibilities among Klebsiella spp. were low: cefoxitin, 73.0%; ceftazidime, 69.4%; and ceftriaxone, 65.9%. Approximately 37% and 28% of K. pneumoniae and E. coli isolates, respectively, were considered ESBL producers based on NCCLS criteria. Ceftriaxone was active against only 52.5% of Enterobacter spp. isolates, whereas cefepime uns active against 90.0% of isolates (MIC50, less than or equal to 0.12 mu g/mL). Oxacillin resistance was detected in nearly 50% of S. aureus isolates. the most active drugs against S. aureus were vancomycin, teicoplanin, and quinupristin/dalfopristin (MIC90, 1 mu g/mL). in summary, our study of pneumonias in Latin American medical centers demonstrated a greatly increased prevalence of Acinetobacter spp, and higher resistance rates among Gram-negative bacilli when compared with similar controlled studies from North America. (C) Elsevier Science Inc.
Idioma Inglês
Data de publicação 1998-12-01
Publicado em Diagnostic Microbiology and Infectious Disease. New York: Elsevier B.V., v. 32, n. 4, p. 289-301, 1998.
ISSN 0732-8893 (Sherpa/Romeo, fator de impacto)
Publicador Elsevier B.V.
Extensão 289-301
Fonte http://dx.doi.org/10.1016/S0732-8893(98)00124-2
Direito de acesso Acesso restrito
Tipo Artigo
Web of Science WOS:000078212800006
Endereço permanente http://repositorio.unifesp.br/handle/11600/25988

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta